JENNIFER MCBREAIRTY: Open Payments
NPI 1083965354 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,739 in 90 payments from 20 companies in 2025. Trend: 2023 $1,476 · 2024 $1,237 · 2025 $1,739
Food & beverage: $1,739
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $203 |
| Lilly USA, LLC | 9 | $192 |
| Novo Nordisk Inc | 10 | $182 |
| ABBVIE INC. | 9 | $158 |
| Lundbeck LLC | 10 | $158 |
| Otsuka America Pharmaceutical, Inc. | 6 | $130 |
| Amgen Inc. | 5 | $91 |
| Esperion Therapeutics, Inc. | 4 | $85 |
| PFIZER INC. | 4 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
Products named: TRELEGY ELLIPTA, REXULTI, Ozempic, VYEPTI, MOUNJARO, NEXLETOL, Kerendia, CAPLYTA.
Industry payments across FL — which companies pay providers there.
